<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230522058251N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-07-31</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>Assessing the effectiveness of VR therapy in the treatment of frozen shoulder</public_title>
      <acronym></acronym>
      <scientific_title>Assessing the effectiveness of Virtual Reality (VR) therapy in patients with frozen shoulder</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-08-30</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/70369</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Sealed envelope
patient chooses a sealed envelope when he enters the study. The envelope contains either of the two labels reading control or intervention.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Frozen shoulder (Adhesive capsulitis).</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: 12 sessions of physiotherapy during 4 weeks (3 sessions each week) was done. Each session lasts one hour. The first 40 minutes was the same in both groups, which contains twenty minutes of passive exercise with CPM machine, followed by twenty minutes of functional exercises including flexion, abduction and external rotation. In the next twenty minutes, the virtual reality device is placed on the patient's head and the patient finds himself in a game environment, wielding a sword in his hand and obliged to hit the obstacles that appear in the game. The speed of the appearance of the obstacles and their arrangement have been adjusted by the study team so that the patient's hand movements as a result of trying to hit the obstacles have a rehabilitative nature. Intervention 2: Control group: 12 sessions of physiotherapy in a period of 4 weeks, 3 sessions each week, was done. The duration of each session was 40 minutes. In each session, after twenty minutes of passive training with the CPM machine, twenty minutes of functional exercises including flexion, abduction and external rotation were performed.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
After de-identifying the participants (name removal), the data can be sent under an excel file including all demographic information and independent variables and results.

When:
all the specified data will be available 6 month after the publication of the results upon request from the corresponding author

To whom:
academic staff of all universities

Conditions:
standard scientific citation, and only to the researchers conducting the same research

Where to obtain:
corresponding author
Mohammad Hossein Mahrooz
mohamad.mahrooz@alum.sharif.edu
Shahid Beheshti University of medical sciences, Tehran, Iran

How to obtain:
A mail or e-mail, requesting the required data, along with an attestation of non-disclosure of information to a third party

Comments:
for any further inquiries please contact the corresponding author via e-mail
mohamad.mahrooz@alum.sharif.edu</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammad Hossein Mahrooz</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Beheshti Medical University, Aarabi st., Daneshjoo Blvd., Shahriari sq., Velenjak</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1985717443</zip>
        <telephone>+98 21 2243 9872</telephone>
        <email>mohamad.mahrooz@alum.sharif.edu</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammad Hossein Mahrooz</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Beheshti Medical University, Aarabi st., Daneshjoo Blvd., Shahriari sq., Velenjak</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1985717443</zip>
        <telephone>+98 21 2243 9872</telephone>
        <email>mohamad.mahrooz@alum.sharif.edu</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Clinical diagnosis of frozen shoulder
Informed consent to comply with the study protocols
age between 18 and 65 years</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>history of trauma or surgery in the affected shoulder
history of any neurologic disease affecting the neuro-muscular function of the affected shoulder
history of migraine
history of seizure
gait dysfunction
vertigo or impaired stability</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M75.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Adhesive capsulitis of shoulder</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: 12 sessions of physiotherapy during 4 weeks (3 sessions each week) was done. Each session lasts one hour. The first 40 minutes was the same in both groups, which contains twenty minutes of passive exercise with CPM machine, followed by twenty minutes of functional exercises including flexion, abduction and external rotation. In the next twenty minutes, the virtual reality device is placed on the patient's head and the patient finds himself in a game environment, wielding a sword in his hand and obliged to hit the obstacles that appear in the game. The speed of the appearance of the obstacles and their arrangement have been adjusted by the study team so that the patient's hand movements as a result of trying to hit the obstacles have a rehabilitative nature.</i_keyword>
      <i_keyword>Control group: 12 sessions of physiotherapy in a period of 4 weeks, 3 sessions each week, was done. The duration of each session was 40 minutes. In each session, after twenty minutes of passive training with the CPM machine, twenty minutes of functional exercises including flexion, abduction and external rotation were performed.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Shoulder function based on ِDisabilities of the Arm, Shoulder and Hand (DASH) questionnaire. Timepoint: before the first session, and after the last session. Method of measurement: Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire.</prim_outcome>
      <prim_outcome>Pain level based on Visual Analogue Scale questionnaire. Timepoint: before the first session and after the final session. Method of measurement: Visual Analogue Score.</prim_outcome>
      <prim_outcome>Patient satisfaction level based on Visual Analogue Scale questionnaire. Timepoint: After the final session. Method of measurement: Visual Analogue Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-05-06</approval_date>
        <contact_name>Iran national commettee for ethics in biomedical research</contact_name>
        <contact_address>Floor 13, Block A, Ministry of Health &amp; Medical Education Headquarters, Between Zarafashan &amp; South Falamak, Qods Town Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
